Brecon Pharmaceuticals has successfully completed the first FDA audit of its Hay-on-Wye facility in Wales, UK, which is now compliant with FDA standards. Brecon is now compliant with European, U.S. and ISO 9001:2008 standards and provides a range of customized primary and secondary commercial and IMP packaging solutions of medications and licensed pharmaceuticals.   Kay O’Hagan, director of Quality Assurance and Regulatory Affairs at Brecon, said, “This is a significant achievement for Brecon. ...